dc.contributor.author |
Allan, Katie |
en |
dc.contributor.author |
Liu, E |
en |
dc.contributor.author |
Allenby, Keith |
en |
dc.date.accessioned |
2011-11-14T20:35:12Z |
en |
dc.date.issued |
2006 |
en |
dc.identifier.citation |
Australian & New Zealand Journal of Obstetrics & Gynaecology 46(5):440-445 2006 |
en |
dc.identifier.issn |
0004-8666 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/9034 |
en |
dc.description.abstract |
Aims: To perform a comparative analysis of antenatal management received according to the results of cervico-vaginal fetal fibronectin (fFN) testing, and to review preterm delivery rates and fFN predictive values within a New Zealand population of women presenting with threatened preterm labour. Methods: Case note review of all fFN tests performed at Middlemore Hospital, South Auckland from August 2003 to March 2005 (n = 199). Data collected included risk factors for preterm delivery, signs and symptoms at presentation, antenatal management received after fFN test and outcome and delivery details. Positive and negative fFN results were compared. Results: Women with a positive fFN were more likely to receive antenatal corticosteroids (96.4 vs 4.7% RR 8.74 (95% CI 5.40–14.17)) and tocolysis (71.4 vs 2.4% RR 8.10 (95% CI 4.49–14.59)) and to be admitted antenatally (96.4 vs 54.4% RR 1.77 (95% CI 1.50–2.10)) with a higher mean cost of treatment ($NZ967.47 vs $NZ335.27 P < 0.05). Rates of delivery < 34 weeks were higher in those with a positive fFN (41.9 vs 0.7% RR 62.06 (95% CI 8.43–457.14)). Conclusion: Women with a positive fFN result received different treatment to those with a negative fFN. Use of fFN test in routine clinical practice allows management and resources to be targeted more appropriately and may limit unnecessary interventions. |
en |
dc.language |
EN |
en |
dc.publisher |
Wiley-Blackwell |
en |
dc.relation.ispartofseries |
Australian and New Zealand Journal of Obstetrics and Gynaecology |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0004-8666/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
fetal fibronectin |
en |
dc.subject |
preterm birth |
en |
dc.subject |
preterm labour |
en |
dc.subject |
MANAGEMENT |
en |
dc.subject |
TRIAL |
en |
dc.subject |
BIRTH |
en |
dc.subject |
ADMISSIONS |
en |
dc.subject |
DIAGNOSIS |
en |
dc.subject |
ACCURACY |
en |
dc.subject |
ASSAY |
en |
dc.title |
The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1111/j.1479-828X.2006.00631.x |
en |
pubs.issue |
5 |
en |
pubs.begin-page |
440 |
en |
pubs.volume |
46 |
en |
dc.rights.holder |
Copyright: 2006 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists |
en |
dc.identifier.pmid |
16953860 |
en |
pubs.end-page |
445 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
92356 |
en |
pubs.org-id |
Liggins Institute |
en |
pubs.record-created-at-source-date |
2010-09-01 |
en |
pubs.dimensions-id |
16953860 |
en |